Related Experiment Video
Updated: May 17, 2026
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Thrombolytic therapy in acute pulmonary embolism
1Division of Pulmonary and Critical Care Medicine, Center for Pulmonary Vascular Disease, Duke University Medical Center, Durham, North Carolina, USA. tapso001@mc.duke.edu
Current Opinion in Cardiology
|October 19, 2012
Summary
Thrombolytic therapy accelerates clot lysis in acute pulmonary embolism (PE). While effective for massive PE, it carries bleeding risks, necessitating careful patient selection.
Area of Science:
- Cardiology
- Pulmonology
- Emergency Medicine
Background:
- Acute pulmonary embolism (PE) poses significant clinical challenges for various medical specialists.
- Decisions regarding thrombolytic therapy for massive and submassive PE are common.
- Existing evidence for thrombolytic use in PE has limitations and unanswered questions.
Purpose of the Study:
- To provide an overview of thrombolytic therapy in acute pulmonary embolism.
- To discuss current guidelines and recent findings related to thrombolytic agents.
- To address ongoing clinical questions regarding thrombolytic use in PE management.
Main Methods:
- Review of existing literature and clinical guidelines on thrombolytic therapy for PE.
- Analysis of recent data on lower-dose tissue plasminogen activator efficacy and safety.
- Discussion of newer thrombolytic agents and their comparative advantages and limitations.
Main Results:
- Thrombolytic therapy promotes rapid lysis of pulmonary emboli.
- Lower doses of tissue plasminogen activator show potential for improved safety and efficacy.
- Newer agents may offer benefits but require further investigation.
Conclusions:
- Thrombolytic therapy is indicated for massive acute pulmonary embolism.
- Patients with acute PE and significant compromise, even without hypotension, may benefit.
- Risk of bleeding complications necessitates careful consideration of thrombolytic therapy.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...